Literature DB >> 6524991

The chemotherapy of rodent malaria XXXVI. Part IV. The activity of a new 8-aminoquinoline, WR 225,448 against exo-erythrocytic schizonts of Plasmodium yoelii yoelii.

W Peters, D Ellis, Y Boulard, I Landau.   

Abstract

Light microscope and ultrastructural studies show that WR 225,448, an 8-aminoquinoline related to primaquine, causes substantial damage to developing pre-erythrocytic (EE) schizonts of Plasmodium yoelii yoelii in the liver of young rats. In addition to lesions of the mitochondria and nuclear membranes, secretory granules in the parasite fail to reach the surrounding host cell cytoplasm across the parasite membrane. The effective dose of WR 225,448 is much lower than that of primaquine. However, hepatic damage is also seen in treated animals. This may be the summation of damage produced by the experimental inoculation of a large quantity of infective salivary gland tissue from mosquitoes (which is also seen in untreated animals) plus toxic effects of the drug itself. Particular attention would have to be directed to this aspect in preclinical toxicity testing of the compound.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6524991

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  1 in total

1.  Successful sporozoite challenge model in human volunteers with Plasmodium vivax strain derived from human donors.

Authors:  Sócrates Herrera; Olga Fernández; María R Manzano; Bermans Murrain; Juana Vergara; Pedro Blanco; Ricardo Palacios; Juan D Vélez; Judith E Epstein; Mario Chen-Mok; Zarifah H Reed; Myriam Arévalo-Herrera
Journal:  Am J Trop Med Hyg       Date:  2009-11       Impact factor: 2.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.